Skip to content

Application of halcyon cone beam CT intelligent imaging in radiotherapy of head and neck malignant tumors

Application of halcyon cone beam CT intelligent imaging in radiotherapy of head and neck malignant tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058774
Enrollment
Unknown
Registered
2022-04-16
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck tumor

Interventions

Group 1 :KV-CBCT and MV-CBCT

Sponsors

Deyang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Tumor radiotherapy patients aged 18 years and above, signed the informed consent; 2. Pathologically confirmed primary, recurrent or metastatic cancer of the head and neck; 3. According to the routine clinical evaluation, it is planned to perform cone-beam CT image-guided intensity-modulated radiotherapy on the Halcyon system; 4. Expect to be able to complete at least 2 radiotherapy sessions; 5. Expected to comply with the test protocol; 6. Willing to accept follow-up visits.

Exclusion criteria

Exclusion criteria: 1. Minors or persons without independent capacity for civil conduct; 2. Patients with significant changes in the anatomical structure of the head and neck after surgery; 3. The effect of thermoplastic film or other conventional fixing methods is not good; 4. Other conditions that the investigator considers inappropriate to participate in this trial.

Design outcomes

Primary

MeasureTime frame
KVCT and MVCT images;

Countries

China

Contacts

Public ContactLiu Qinghua

Deyang People's Hospital of Sichuan Province

lqhwll@hotmail.com+86 18280539457

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026